Skip to main content
Premium Trial:

Request an Annual Quote

SigmaPlot 8.0, Onto-Express


SPSS has released a new version of its SigmaPlot scientific graphing software, SigmaPlot 8.0, that can generate professional graphs from a Microsoft Excel worksheet. It also includes new toolbar palettes that allow users to modify bars, lines, highlight groups or data, and modify numerous items at once. Users can directly edit text on the graph page, and can modify font size, type, color, and alignments. SigmaPlot 8.0 is selling for $699. Upgrades are available for $199 for SigmaPlot 7.1 and 6.0, and $299 for SigmaPlot 5.0 or lower. For users of SigmaPlot 7.1 2001, the update is available for free at


The Wayne State University Department of Computer Science in Detroit has released version 1.5 of Onto-Express, a functional gene expression analysis tool that allows users to input the set of differentially regulated genes in an experiment, and then returns information about the set of biological processes in which these genes are involved.

The new version supports the mouse genome, as well as “dramatic improvements in speed,” said Sorin Draghici, assistant professor of computer science at Wayne State and the Onto-Express creator. “Results for most queries will now be displayed in less than one minute.” The update also includes a button that launches a sample query, in order to demonstrate to new users how Onto-Expresses works. Onto-Express is available for free at:

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more